|
|
|
| ... | |||||
 |
Caryolysine®
10 mg Solution (Vial) Chlormethine HCL |
 |
Vepeside®
50 mg Etoposide |
||
|
|
|||||
 |
|||||
 |
|||||
 |
|||||
| Indication: Injectable form: Hodgkin’s disease by polychemiotherapy. Topic form : Mycosis fungoides, psoriasis for adults |
Indication: Treatment of breast and lung cancer, lymphoma, leukaemia, testicular carcinoma |
||||
 |
 |
Ethyol®
50 mg/ml
Lyophilisat IV Vial 375 & 500 mg Amifostine |
 |
Thiotepa
® 15 mg Lyophilisat IV (Vial)
Thiothepa |
|
 |
|||||
 |
|||||
 |
|||||
 |
|||||
| Indication: Radioprotection in head and neck cancers. Chimioprotection in ovarian carcinoma (FIGO III or IV)) and solid non-germ tumors |
Indication: Treatment of ovary, breast and bladder cancer. Used for bone marrow and stem cells transplantations. Orphan drug status |
||||
 |
|||||
|
Contact
us :
|
2
Rue Niels Bohr - ZI de l'Esplanade 77400 ST THIBAULT DES VIGNES FRANCE |
||||
Onco-Hemato